Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode
Miller, Lisa M. and Keune, Willem-Jan and Castagna, Diana and Young, Louise C. and Duffy, Emma L. and Potjewyd, Frances and Salgado-Polo, Fernando and Garcia, Paloma Engel and Semaan, Dima and Pritchard, John M. and Perrakis, Anastassis and Macdonald, Simon J. F. and Jamieson, Craig and Watson, Allan J. B. (2017) Structure-activity relationships of small molecule autotaxin inhibitors with a discrete binding mode. Journal of Medicinal Chemistry, 60 (2). pp. 722-748. ISSN 0022-2623 (https://doi.org/10.1021/acs.jmedchem.6b01597)
Preview |
Text.
Filename: Miller_etal_JMC_2016_Structure_activity_relationships_of_small_molecule_autotaxin_inhibitors.pdf
Accepted Author Manuscript Download (3MB)| Preview |
Abstract
Autotaxin (ATX) is a secreted enzyme responsible for the hydrolysis of lysophosphatidylcholine (LPC) to the bioactive lysophosphatidic acid (LPA) and choline. The ATX-LPA signalling pathway is implicated in cell survival, migration, and proliferation; thus, the inhibition of ATX is a recognized therapeutic target for a number of diseases including fibrotic diseases, cancer, and inflammation, amongst others. Many of the developed synthetic inhibitors for ATX have resembled the lipid chemotype of the native ligand; however, a small number of inhibitors have been described that deviate from this common scaffold. Herein, we report the structure-activity relationships (SAR) of a previously reported small molecule ATX inhibitor. We show through enzyme kinetics studies that analogues of this chemotype are noncompetitive inhibitors, and using a crystal structure with ATX we confirm the discrete binding mode.
ORCID iDs
Miller, Lisa M.




-
-
Item type: Article ID code: 59242 Dates: DateEvent26 January 2017Published16 December 2016Published Online16 December 2016AcceptedSubjects: Science > Chemistry
Medicine > Pharmacy and materia medicaDepartment: Faculty of Science > Pure and Applied Chemistry
Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Strategic Research Themes > Health and WellbeingDepositing user: Pure Administrator Date deposited: 22 Dec 2016 14:06 Last modified: 22 Feb 2025 01:40 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/59242